Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. | 0 | déclaré | 16 sept. 2025 | tx 205+2 721 008−4 724 209 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 16 sept. 2025 | TENDER | Y-mAbs Therapeutics, Inc. | 60 000 | 8.60 USD | |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 60 235 | — | |
| 16 sept. 2025 | TENDER | Y-mAbs Therapeutics, Inc. | 245 486 | 8.60 USD | |
| 16 sept. 2025 | TENDER | Y-mAbs Therapeutics, Inc. | 67 681 | 8.60 USD | |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 60 000 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 110 000 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 91 450 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 130 000 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 107 500 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 100 000 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 16 000 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 143 169 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 16 000 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 16 000 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 64 000 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 132 500 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 242 200 | — | deriv |
| 16 sept. 2025 | OTHER | Y-mAbs Therapeutics, Inc. | 75 000 | — | deriv |
| 03 juin 2025 | EXERCISE | Y-mAbs Therapeutics, Inc. | 103 000 | 2.00 USD | |
| 03 juin 2025 | EXERCISE | Y-mAbs Therapeutics, Inc. | 103 000 | 0.00 USD | deriv |
| 07 mars 2025 | SALE | Y-mAbs Therapeutics, Inc. | 10 810 | 5.23 USD | |
| 17 janv. 2025 | GRANT_AWARD | Y-mAbs Therapeutics, Inc. | 32 000 | 0.00 USD | |
| 17 janv. 2025 | GRANT_AWARD | Y-mAbs Therapeutics, Inc. | 64 000 | 0.00 USD | deriv |
| 19 sept. 2024 | EXERCISE | Y-mAbs Therapeutics, Inc. | 22 831 | 4.38 USD | |
| 19 sept. 2024 | EXERCISE | Y-mAbs Therapeutics, Inc. | 22 831 | 0.00 USD | deriv |